Tags: Drug.
Abagovomab is a mouse anti-idiotype monoclonal antibody whose variable epitope mirrors a tumour antigen (CA-125) highly expressed in the epithelial ovarian cancer. Abagovomab does not bind directly to CA-125 but it works as a surrogate antigen enabling the immune system to identify and attack tumour cells displaying the CA-125 protein.
